Cargando…

Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer

PURPOSE: In value-based health care delivery, radiation oncologists need to compare empiric costs of care delivery with advanced technologies, such as intensity-modulated proton therapy (IMPT) and intensity-modulated radiation therapy (IMRT). We used time-driven activity-based costing (TDABC) to com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thaker, Nikhil G., Boyce-Fappiano, David, Ning, Matthew S., Pasalic, Dario, Guzman, Alexis, Smith, Grace, Holliday, Emma B., Incalcaterra, James, Garden, Adam S., Shaitelman, Simona F., Gunn, G. Brandon, Fuller, C. David, Blanchard, Pierre, Feeley, Thomas W., Kaplan, Robert S., Frank, Steven J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Particle Therapy Co-operative Group 2021
Materias:	Health Policy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270081/ https://www.ncbi.nlm.nih.gov/pubmed/34285963 http://dx.doi.org/10.14338/IJPT-20-00042.1

Ejemplares similares

Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer
por: Smith, Grace L., et al.
Publicado: (2021)

Evaluating single-institution resource costs of consolidative radiotherapy for oligometastatic non-small cell lung cancer using time-driven activity-based costing
por: Pezzi, Todd A., et al.
Publicado: (2020)

Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer
por: Jensen, Garrett L., et al.
Publicado: (2017)

Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy
por: Ng, Sweet Ping, et al.
Publicado: (2020)

Cost-Effectiveness Models of Proton Therapy for Head and Neck: Evaluating Quality and Methods to Date
por: Huang, Danmeng, et al.
Publicado: (2021)

Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis
por: Boyce-Fappiano, D., et al.
Publicado: (2021)

Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma
por: Elhalawani, Hesham, et al.
Publicado: (2020)

Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer
por: Aggarwal, Puja, et al.
Publicado: (2021)

Methodologies to Increase the Level of Evidence of Real-life Proton Therapy in Head and Neck Tumors
por: Dionisi, Francesco, et al.
Publicado: (2021)

Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: Potential for improvement over time?
por: Stieb, Sonja, et al.
Publicado: (2020)

Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy
por: Taku, Nicolette, et al.
Publicado: (2021)

Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT
por: Mohamed, Abdallah S.R., et al.
Publicado: (2018)

Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors
por: Aggarwal, Puja, et al.
Publicado: (2022)

The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors
por: Stieb, Sonja, et al.
Publicado: (2020)

Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of Life
por: Sherry, Alexander D., et al.
Publicado: (2021)

Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities
por: Boyce-Fappiano, David, et al.
Publicado: (2021)

Radiation-Induced Hypothyroidism After Radical Intensity Modulated Radiation Therapy for Oropharyngeal Carcinoma
por: Kamal, Mona, et al.
Publicado: (2019)

Association of hearing loss and tinnitus symptoms with health‐related quality of life among long‐term oropharyngeal cancer survivors
por: Aggarwal, Puja, et al.
Publicado: (2022)

(18)FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer
por: Elhalawani, Hesham, et al.
Publicado: (2021)

Integrated primary health care in Australia
por: Davies, Gawaine Powell, et al.
Publicado: (2009)

Telerehabilitation Policy Report: Interprofessional Policy Principles and Priorities
por: Terrell, Evelyn Abrahante, et al.
Publicado: (2021)

Implementation of medicinal cannabis in Australia: innovation or upheaval? Perspectives from physicians as key informants, a qualitative analysis
por: Hallinan, Christine Mary, et al.
Publicado: (2021)

RELATIONSHIP BETWEEN FINANCIAL IMPACT AND COVERAGE OF DRUGS IN AUSTRALIA
por: Mauskopf, Josephine, et al.
Publicado: (2013)

Effects and side-effects of integrating care: the case of mental health care in the Netherlands
por: Hutschemaekers, Giel J.M., et al.
Publicado: (2007)

EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease
por: Losekoot, Monique, et al.
Publicado: (2013)

The Role of Funding and Policies on Innovation in Cancer Drug Development
por: Kanavos, P, et al.
Publicado: (2010)

FROM TALK TO ACTION: POLICY STAKEHOLDERS, APPROPRIATENESS, AND SELECTIVE DISINVESTMENT
por: Paprica, P. Alison, et al.
Publicado: (2015)

The state of research into children with cancer across Europe: new policies for a new decade
por: Pritchard-Jones, K, et al.
Publicado: (2011)

Multidisciplinary approach to COVID-19 and cancer: consensus from scientific societies in Argentina
por: Ismael, Julia, et al.
Publicado: (2020)

American Telemedicine Association’s Principles for Delivering Telerehabilitation Services
por: RICHMOND, TAMMY, et al.
Publicado: (2017)

Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21(st) century
por: Garden, Adam S, et al.
Publicado: (2013)

One small edit for humans, one giant edit for humankind? Points and questions to consider for a responsible way forward for gene editing in humans
por: Howard, Heidi C., et al.
Publicado: (2017)

ESHG PPPC Comments on postmortem use of genetic data for research purposes
por: Fellmann, Florence, et al.
Publicado: (2019)

Recommendations for reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic)
por: Claustres, Mireille, et al.
Publicado: (2014)

Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2
por: Kamsteeg, Erik-Jan, et al.
Publicado: (2012)

European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death
por: Fellmann, Florence, et al.
Publicado: (2019)

Brazilian Group of Gastrointestinal Tumours’ consensus guidelines for the management of oesophageal cancer
por: Rocha-Filho, Duilio R, et al.
Publicado: (2021)

EMQN best practice guidelines for the molecular genetic testing and reporting of chromosome 11p15 imprinting disorders: Silver–Russell and Beckwith–Wiedemann syndrome
por: Eggermann, Katja, et al.
Publicado: (2016)

Responsible implementation of expanded carrier screening
por: Henneman, Lidewij, et al.
Publicado: (2016)

An Association of Cancer Physicians’ strategy for improving services and outcomes for cancer patients
por: Baird, Richard, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dl6auhhscv2ud4sivasq09b9o8